سوق القنب الطبي في منطقة آسيا والمحيط الهادئ – اتجاهات الصناعة والتوقعات حتى عام 2030

Customize Your Report تخصيص تقريرك Buy Now اشتري الآن Free Sample Report تقرير عينة مجاني
Home Pharmaceutical Asia Pacific Medical Cannabis Market
Request for TOC طلب جدول المحتويات Speak to Analyst تحدث إلى المحلل Buy Now اشتري الآن Inquire Before Buying استفسر قبل Free Sample Report تقرير عينة مجاني

سوق القنب الطبي في منطقة آسيا والمحيط الهادئ – اتجاهات الصناعة والتوقعات حتى عام 2030

  • Pharmaceutical
  • Published Report
  • May 2023
  • Asia-Pacific
  • 350 الصفحات
  • عدد الجداول: 877
  • عدد الأرقام: 51
Buy Now اشتري الآن

Asia Pacific Medical Cannabis Market

حجم السوق بالمليار دولار أمريكي

CAGR :  % Diagram

Diagram فترة التنبؤ
 2024 –2030
Diagram حجم السوق (السنة الأساسية)
 مليون دولار أمريكي
طلب
Diagram حجم السوق (سنة التنبؤ)
 USD MILLION
Request For Unlock
Diagram CAGR
 %
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
طلب فتح القفل

>سوق القنب الطبي في آسيا والمحيط الهادئ، حسب المنتج (الزيت، كبسولات القنب الطبي، الرقعة، الزهرة الكاملة، الزهرة المطحونة، قلم التبخير، القنب الطبي المجفف، الكريمات والمرطبات، الأقنعة والمصل، المنظف، وغيرها)، المصدر (طبيعي وصناعي)، الأنواع (القنب إنديكا، ساتيفا، والهجين)، التطبيق ( مرض الزهايمر ، فقدان الشهية، السرطان، أمراض الأمعاء الالتهابية، اضطرابات الأكل، الصرع، التوحد، حالات الصحة العقلية، التصلب المتعدد، إدارة الألم، الغثيان، تشنجات العضلات، متلازمة الهزال (الضمور العضلي)، تحسين الحالة المزاجية، الاكتئاب واضطرابات النوم، القلق، وغيرها)، المشتقات (كانابيديول (CBD)، رباعي هيدروكانابينول (THC) / دلتا-8-رباعي هيدروكانابينول، كانابينول (CBN)، كانابيسيكلول (CBL)، كانابيكرومين (CBC)، كانابيجيرول (CBG)، وغيرها)، نوع العلاج (طارد للبلغم، مضاد للفيروسات، مسكن للألم، مثير للشهوة الجنسية، مخدر، وغيرها)، طريق الإدارة (المحاليل الفموية والكبسولات، التدخين، أجهزة التبخير، الموضعية، وغيرها)، المستخدم النهائي (صناعة الأدوية، مراكز البحث والتطوير، بيئة الرعاية المنزلية، المستشفى، مراكز إعادة التأهيل وغيرها)، قناة التوزيع (B2B وB2C) - اتجاهات الصناعة وتوقعاتها حتى عام 2030.

سوق القنب الطبي في منطقة آسيا والمحيط الهادئ

تحليل ورؤى حول سوق القنب الطبي في منطقة آسيا والمحيط الهادئ

ومن المتوقع أن يؤدي ارتفاع عدد المرضى المصابين بأمراض مزمنة في منطقة آسيا والمحيط الهادئ والميل المتزايد نحو نمط حياة صحي إلى دفع نمو السوق. بالإضافة إلى ذلك، من المتوقع أن يؤدي ارتفاع عدد الموافقات على المنتجات وزيادة أنشطة البحث والتطوير لأجهزة القنب الطبي إلى دفع نمو السوق. ومع ذلك، من المتوقع أن تؤدي التكلفة العالية لأجهزة وإجراءات القنب الطبي والأدوية الطبية والمخاوف المتعلقة بالسلامة والآثار السلبية المرتبطة بإجراءات الليزر والافتقار إلى الوعي بالعلاج بأجهزة الليزر إلى كبح نمو السوق. ومن المتوقع أن تعمل التطورات التكنولوجية الإضافية في القنب الطبي والمبادرات الاستراتيجية من قبل اللاعبين الناشئين كفرص لنمو السوق. ومع ذلك، من المتوقع أن تشكل اللوائح الصارمة ونقص المهنيين المهرة تحديًا لنمو السوق.

سوق القنب الطبي في منطقة آسيا والمحيط الهادئ

سوق القنب الطبي في منطقة آسيا والمحيط الهادئ

لا يتم اختبار استخدام القنب كدواء بشكل صارم بسبب القيود الحكومية مما يؤدي إلى أبحاث سريرية محدودة لتحديد فعالية القنب في التطبيقات الطبية والسريرية. ومع ذلك، تشير الدراسات الأولية إلى أن القنب يقلل من القيء والغثيان لدى مرضى العلاج الكيميائي ويساعد في زيادة الشهية.

تحلل شركة Data Bridge Market Research أن سوق القنب الطبي في منطقة آسيا والمحيط الهادئ من المتوقع أن ينمو بمعدل نمو سنوي مركب نسبته 22.3٪ خلال الفترة المتوقعة من 2023 إلى 2030.

تقرير القياس

تفاصيل

فترة التنبؤ

2023 إلى 2030

سنة الأساس

2022

سنة تاريخية

2021 (قابلة للتخصيص حتى 2015 – 2020)

وحدات كمية

الإيرادات بالملايين من الدولارات الأمريكية

القطاعات المغطاة

المنتج (الزيت، كبسولات القنب الطبي، الرقعة، الزهرة الكاملة، الزهرة المطحونة، قلم التبخير، القنب الطبي المجفف، الكريمات والمرطبات، الأقنعة والمصل، المنظف، وغيرها)، المصدر (طبيعي وصناعي)، الأنواع (القنب إنديكا، ساتيفا، والهجين)، الاستخدام (مرض الزهايمر، فقدان الشهية، السرطان، أمراض الأمعاء الالتهابية، اضطرابات الأكل، الصرع، التوحد، حالات الصحة العقلية، التصلب المتعدد، إدارة الألم، الغثيان، تشنجات العضلات، متلازمة الهزال (الضمور العضلي)، تحسين الحالة المزاجية، الاكتئاب واضطرابات النوم، القلق، وغيرها)، المشتقات (كانابيديول (CBD)، رباعي هيدروكانابينول (THC) / دلتا-8-رباعي هيدروكانابينول، كانابينول (CBN)، كانابيسيكلول (CBL)، كانابيكرومين (CBC)، كانابيجيرول (CBG)، وغيرها)، نوع العلاج (طارد للبلغم، مضاد للفيروسات، مسكن للألم، مثير للشهوة الجنسية، مخدر، وغيرها)، طريق الإدارة (المحاليل الفموية والكبسولات، التدخين، أجهزة التبخير، الموضعية، وغيرها)، المستخدم النهائي (صناعة الأدوية، مراكز البحث والتطوير، بيئة الرعاية المنزلية، المستشفى، مراكز إعادة التأهيل وغيرها)، قناة التوزيع (B2B وB2C)

الدول المغطاة

أستراليا، تايلاند، كوريا الجنوبية، اليابان، الصين، نيوزيلندا، سنغافورة، الهند، تايوان، ماليزيا، الفلبين، وبقية دول آسيا والمحيط الهادئ

الجهات الفاعلة في السوق المشمولة

MediPharm Labs Inc.، Tilray، Aurora Cannabis، JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc)، HEXO Corp. (Zenabis Asia-Pacific Ltd)، Cresco Labs، Peace Naturals Project Inc.، CANOPY GROWTH CORPORATION، Medical Marijuana, Inc.، Seed Cellar، EcoGen Biosciences، CANNABIS SEEDS USA، Seeds For Me، HUMBOLDT SEED COMPANY، Extractas، World Class Cannabis Seeds (Crop King Seeds)، BARNEY'S FARM، FOLIUM BIOSCIENCES، PharmaHemp، Elixinol Asia-Pacific Limited، ENDOCA، Harmony، MARY'S nutritions, LLC، Pure Ratios، Greenwich Biosciences, Inc.، Upstate Elevator Supply Co.، Apothecanna، BOL Pharma، وIDT Australia وغيرها

تعريف السوق

القنب هو عقار نفسي مشتق من نبات القنب من عائلة القنبيات. منذ عدة سنوات، تم استخدامه طبيًا وله مجموعة واسعة من التطبيقات في علاج أمراض مختلفة بما في ذلك الألم المزمن والسرطان والاكتئاب والسكري والتهاب المفاصل والزرق والصرع والصداع النصفي والإيدز ومرض الزهايمر وغيرها.

ومن المتوقع أن يؤدي الاستخدام المتزايد للقنب لأغراض طبية، والتشريع المنظم للقنب واستخدامه في مختلف الصناعات، والمنهجيات المتقدمة الموجودة في هذا المجال إلى دفع نمو السوق.

ديناميكيات سوق القنب الطبي في منطقة آسيا والمحيط الهادئ

يتناول هذا القسم فهم محركات السوق والمزايا والفرص والقيود والتحديات. ويتم مناقشة كل هذا بالتفصيل على النحو التالي:

السائقين

  • زيادة استخدام القنب في الأدوية

يتم استخراج القنب الطبي من نباتات القنب ويمكن استخدامه لعلاج أعراض بعض الحالات الطبية والآثار الجانبية لبعض العلاجات. الشكل الأكثر شيوعًا للاستخدام الطبي للقنب هو إدارة الألم. كان هناك قبول واستخدام تدريجي للقنب الطبي مع العدد المتزايد من البلدان التي شرعت استخدام القنب لمختلف المؤشرات. تمت الموافقة على استخدام القنب الطبي من قبل إدارة الغذاء والدواء لثلاثة مؤشرات وهي أشكال نادرة وشديدة من الصرع ومتلازمة درافيت ومتلازمة لينوكس غاستو وأيضًا لعلاج التشنج في مرض التصلب المتعدد (MS).

تستخدم الماريجوانا الطبية نبات الماريجوانا أو المواد الكيميائية الموجودة فيه لعلاج الأمراض أو الحالات، وبصرف النظر عن الأدوية المعتمدة، هناك اهتمام متزايد باثنين من القنب وهما دلتا-9-تتراهيدروكانابينول وكانابيديول. وقد ثبت أن رباعي هيدروكانابينول يحسن الشهية ويقلل من التعب ويدير مشاكل وظائف العضلات بينما كان الكانابيديول فعالاً في إدارة النوبات الصرعية وعلاج الأمراض النفسية وتقليل الالتهابات.

  • تشريع القنب

يستمر استخدام وقبول القنب الطبي في التطور، حيث يسمح عدد متزايد من الولايات باستخدام مؤشرات طبية محددة. وقد شرعت العديد من البلدان الماريجوانا للأغراض الطبية أو الترفيهية بينما فرضت بعض البلدان الأخرى استخدامًا مقيدًا. في السنوات الأخيرة، شرعت عدد متزايد من الولايات في الولايات المتحدة المخدرات للأغراض الطبية أو الترفيهية. ومع انتشار تقنين القنب على نطاق واسع، أصبحت العديد من الشركات أيضًا نشطة وتتخذ مبادرات لتقنين القنب بالكامل.

يمكن النظر إلى تقنين الماريجوانا في مختلف أنحاء العالم على أنه جهد لزيادة الإيرادات الإضافية، وبهذه الطريقة سيكون هناك زيادة في الإيرادات دون رفع الضرائب. سيسمح تقنين القنب باستهلاك المزيد منه للأغراض الطبية أو الترفيهية. علاوة على ذلك، سيعزز أيضًا تجارة القنب، وبالتالي يخلق المزيد من الطلب على القنب. وبالتالي، من المتوقع أن يؤدي تقنين القنب إلى دفع نمو السوق.

فرص

  • تطوير منتجات جديدة مع زيادة أنشطة البحث والتطوير

يأتي القنب الطبي في أشكال مختلفة عديدة بما في ذلك الكبسولات والعلكة القابلة للمضغ والكريمات والبلورات والزهور والأقراص والزيت وبخاخات الغشاء المخاطي للفم. أدى النمو المرتفع في الطلب على القنب مع إضفاء الشرعية على الحاجة إلى التوصل إلى سلالات منتجات وأنظمة توصيل أفضل. وقد دفع هذا العديد من الشركات إلى إجراء أنشطة البحث والتطوير للتحقق من استراتيجيات التحسين الجيني للقنب. تعمل لجنة منتجات القنب التابعة لإدارة الغذاء والدواء على تطوير وتنفيذ استراتيجيات وسياسات عبر الوكالات لتنظيم منتجات القنب. المنتجات الجديدة التي تم تطويرها وتزايدت هي مساحيق بروتين القنب وألواح الطاقة وحليب القنب ودقيق القنب وشاي القنب، والتي من المتوقع أن تخلق فرصًا لنمو السوق.

  • زيادة استخدام القنب لأغراض ترفيهية

إن تقنين الماريجوانا الترفيهية يؤدي إلى تنظيم مفيد لعقار آمن، دون زيادة العواقب السلبية المحتملة. إن تقنين الماريجوانا له فوائد مجتمعية مختلفة مثل ارتفاع الاقتصاد دون زيادة الضرائب، وخلق الآلاف من فرص العمل، ووقف الاختلافات العرقية في إنفاذ الماريجوانا، وتحرير موارد الشرطة الشحيحة. يمكن أن يؤدي تقنين الماريجوانا الترفيهية إلى إنهاء فرض قوانين الماريجوانا المكلفة وإضعاف سوق الماريجوانا غير القانونية.

وبفضل هذه الفوائد، تم تشريع الماريجوانا وتبنيها بشكل متزايد من قبل أشخاص من مختلف الفئات العمرية. وهذا يخلق طلبًا على الماريجوانا عالية الجودة من أجل المتعة والاسترخاء. وبالتالي، من المتوقع أن يؤدي التبني المتزايد للقنب لأغراض ترفيهية إلى خلق فرص للمصنعين في السوق.

ضبط النفس/التحدي

  • شراء باهظ التكلفة والتسرع في الحصول على الجودة الممتازة

قد تكون تكلفة تصنيع وشراء أجهزة القنب الطبي باهظة الثمن، وقد تكون تكلفة الإجراء مرتفعة أيضًا بسبب المعدات المتخصصة والتدريب المطلوب. وقد يحد هذا من إمكانية الوصول إلى علاجات القنب الطبي للمرضى ومرافق الرعاية الصحية، وخاصة في المناطق ذات الدخل المنخفض. بالإضافة إلى ذلك، قد تمنع التكلفة المرتفعة لأجهزة وإجراءات القنب الطبي بعض المرضى من اختيار هذه العلاجات، خاصة إذا كان عليهم الدفع من جيوبهم الخاصة. كما يمكن أن تكون التغطية التأمينية لعلاجات القنب الطبي محدودة، مما يحد من تبنيها.

ونتيجة لذلك، فإن التكلفة المرتفعة لأجهزة وإجراءات القنب الطبي يمكن أن تشكل عائقًا كبيرًا أمام نمو السوق، وخاصة في المناطق حيث التكلفة هي عامل رئيسي. ومع ذلك، مع تقدم التكنولوجيا، قد تنخفض تكلفة هذه الأجهزة والإجراءات، مما يجعلها في متناول المرضى ومرافق الرعاية الصحية.

ومن المتوقع أن يؤدي التعقيد المتزايد لأجهزة القنب الطبي والتكلفة العالية لعلاج القنب الطبي إلى كبح نمو السوق.

التطورات الأخيرة

  • في مايو 2018، وفقًا لقانون القنب الصادر عن حكومة كندا، سيخلق قانون القنب إطارًا قانونيًا صارمًا للسيطرة على إنتاج وتوزيع وبيع وحيازة القنب في جميع أنحاء كندا والذي يهدف إلى إبقاء القنب بعيدًا عن أيدي الشباب والأرباح بعيدًا عن جيوب الجريمة المنظمة من خلال تعزيز صناعة قانونية ومنظمة قوية.

نطاق سوق القنب الطبي في منطقة آسيا والمحيط الهادئ

يتم تقسيم سوق القنب الطبي في منطقة آسيا والمحيط الهادئ إلى تسعة قطاعات بارزة بناءً على المنتج والمصدر والأنواع والمشتقات والتطبيق وطريقة الإدارة ونوع العلاج والمستخدم النهائي وقناة التوزيع. سيساعدك النمو بين هذه القطاعات على تحليل قطاعات نمو السوق في الصناعات وتزويد المستخدمين بنظرة عامة قيمة على السوق ورؤى السوق لمساعدتهم على اتخاذ قرارات استراتيجية لتحديد تطبيقات السوق الأساسية.

منتج

  • زيت
  • القنب الطبي المجفف
  • كبسولات القنب الطبي
  • قلم فيب
  • الزهرة كاملة
  • كريمات ومرطبات
  • زهرة الارض
  • رقعة
  • أقنعة و مصل
  • منظف
  • آحرون

على أساس المنتج، يتم تقسيم السوق إلى زيت، كبسولات القنب الطبي، رقعة، زهرة كاملة، زهرة مطحونة، قلم vape، القنب الطبي المجفف، الكريمات والمرطبات، الأقنعة والمصل، المنظف، وغيرها .

مصدر

  • اصطناعي
  • طبيعي

على أساس المصدر، يتم تقسيم السوق إلى اصطناعية وطبيعية.

صِنف

  • القنب الهندي
  • ساتيفا
  • هجين

على أساس الأنواع، يتم تقسيم السوق إلى القنب إنديكا، وساتيفا، والهجين.

المشتقات

  • كانابيديول (CBD)
  • رباعي هيدرو كانابينول (THC)/ دلتا-8-رباعي هيدرو كانابينول
  • كانابيجيرول (CBG)
  • كانابيكرومين (CBC)
  • كانابينول (CBN)
  • كانابيسايكلول (CBL)
  • آحرون

على أساس المشتقات، يتم تقسيم السوق إلى كانابيديول (CBD)، رباعي هيدروكانابينول (THC) / دلتا-8-رباعي هيدروكانابينول، كانابينول (CBN)، كانابيسيكلول (CBL)، كانابيكرومين (CBC)، كانابيجيرول (CBG)، وغيرها.

طلب

  • إدارة الألم
  • قلق
  • تشنّج عضلي
  • غثيان
  • فقدان الشهية
  • اضطرابات الأكل
  • أمراض الأمعاء الالتهابية
  • سرطان
  • التهاب المفاصل
  • متلازمة الهزال (الهزال)
  • مرض الزهايمر
  • الصرع
  • الاكتئاب واضطرابات النوم
  • تصلب متعدد
  • توحد
  • حالات الصحة العقلية
  • تحسين المزاج
  • آحرون

على أساس التطبيق، يتم تقسيم السوق إلى مرض الزهايمر، وفقدان الشهية، والسرطان، وأمراض الأمعاء الالتهابية، واضطرابات الأكل، والصرع، والتوحد، وحالات الصحة العقلية، والتصلب المتعدد، وإدارة الألم، والغثيان، وتشنجات العضلات، ومتلازمة الهزال (الضمور العضلي)، وتحسين الحالة المزاجية، والتصلب المتعدد، والاكتئاب واضطرابات النوم، والقلق، وغيرها.

طريق الإدارة

  • المحاليل الفموية والكبسولات
  • تدخين
  • مبخرات
  • المواضيع
  • آحرون

على أساس طريق الإدارة، يتم تقسيم السوق إلى حلول فموية وكبسولات، وتدخين، وأجهزة تبخير، وموضعية، وغيرها.

نوع العلاج

  • مسكن
  • مخدر
  • مضاد فيروسات
  • مثير للشهوة الجنسية
  • مقشع
  • آحرون

على أساس نوع العلاج، يتم تقسيم السوق إلى مقشع، مضاد للفيروسات، مسكن للألم، مثير للشهوة الجنسية، مخدر، وغيرها.

المستخدم النهائي

  • إعداد الرعاية المنزلية
  • مستشفى
  • مراكز إعادة التأهيل
  • صناعة الادوية
  • مراكز البحث والتطوير
  • آحرون

على أساس المستخدم النهائي، يتم تقسيم السوق إلى صناعة الأدوية، ومراكز البحث والتطوير، وإعدادات الرعاية المنزلية، والمستشفيات، ومراكز إعادة التأهيل، وغيرها.

قناة التوزيع

  • ب2ب
  • ب2م

على أساس قناة التوزيع، يتم تقسيم السوق إلى B2B و B2C.

سوق القنب الطبي في منطقة آسيا والمحيط الهادئ

تحليل/رؤى إقليمية لسوق القنب الطبي في منطقة آسيا والمحيط الهادئ

يتم تقسيم سوق القنب الطبي في منطقة آسيا والمحيط الهادئ إلى تسعة قطاعات بارزة بناءً على المنتج والمصدر والأنواع والمشتقات والتطبيق وطريقة الإدارة ونوع العلاج والمستخدم النهائي وقناة التوزيع.

الدول التي يغطيها تقرير السوق هذا هي أستراليا وتايلاند وكوريا الجنوبية واليابان والصين ونيوزيلندا وسنغافورة والهند وتايوان وماليزيا والفلبين وبقية دول آسيا والمحيط الهادئ.

من المتوقع أن تهيمن أستراليا على سوق القنب الطبي في منطقة آسيا والمحيط الهادئ بسبب وجود الشركات المصنعة الرئيسية والعمليات التكنولوجية المتقدمة.

كما يوفر قسم الدولة في التقرير عوامل فردية مؤثرة على السوق والتغييرات في التنظيم في السوق محليًا والتي تؤثر على الاتجاهات الحالية والمستقبلية للسوق. تعد نقاط البيانات مثل المبيعات الجديدة ومبيعات الاستبدال والتركيبة السكانية للدولة والقوانين التنظيمية ورسوم الاستيراد والتصدير من بين المؤشرات الرئيسية المستخدمة للتنبؤ بسيناريو السوق للدول الفردية. كما يتم النظر في وجود وتوافر العلامات التجارية الإقليمية والتحديات التي تواجهها بسبب المنافسة الكبيرة أو النادرة من العلامات التجارية المحلية والمحلية، وتأثير قنوات المبيعات أثناء تقديم تحليل تنبؤي لبيانات الدولة

تحليل المشهد التنافسي وحصة سوق القنب الطبي في منطقة آسيا والمحيط الهادئ

يوفر المشهد التنافسي لسوق القنب الطبي في منطقة آسيا والمحيط الهادئ تفاصيل عن المنافسين. تتضمن التفاصيل نظرة عامة على الشركة، والبيانات المالية للشركة، والإيرادات المتولدة، وإمكانات السوق، والاستثمار في البحث والتطوير، ومبادرات السوق الجديدة، والحضور الإقليمي، ومواقع الإنتاج والمرافق، ونقاط القوة والضعف للشركة، وإطلاق المنتج، وخطوط أنابيب التجارب السريرية، وتحليل العلامة التجارية، وموافقات المنتج، وبراءات الاختراع، وعرض المنتج ونطاقه، وهيمنة التطبيق، ومنحنى شريان الحياة التكنولوجي. تتعلق نقاط البيانات المذكورة أعلاه فقط بتركيز الشركات فيما يتعلق بالسوق.

بعض اللاعبين الرئيسيين في السوق الذين يعملون في هذا السوق هم MediPharm Labs Inc. و Tilray و Aurora Cannabis و JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc) و HEXO Corp. (Zenabis Asia-Pacific Ltd) و Cresco Labs و Peace Naturals Project Inc. و CANOPY GROWTH CORPORATION و Medical Marijuana, Inc. و Seed Cellar و EcoGen Biosciences و CANNABIS SEEDS USA و Seeds For Me و HUMBOLDT SEED COMPANY و Extractas و World Class Cannabis Seeds (Crop King Seeds) و BARNEY'S FARM و FOLIUM BIOSCIENCES و PharmaHemp و Elixinol Asia-Pacific Limited و ENDOCA و Harmony و MARY'S nutritions, LLC و Pure Ratios و Greenwich Biosciences, Inc. و Upstate Elevator Supply Co. Apothecanna، وBOL Pharma، وIDT Australia وغيرها.

SKU-

احصل على إمكانية الوصول عبر الإنترنت إلى التقرير الخاص بأول سحابة استخبارات سوقية في العالم

Sample Image Click on image to enlarge
  • لوحة معلومات تحليل البيانات التفاعلية
  • لوحة معلومات تحليل الشركة للفرص ذات إمكانات النمو العالية
  • إمكانية وصول محلل الأبحاث للتخصيص والاستعلامات
  • تحليل المنافسين باستخدام لوحة معلومات تفاعلية
  • آخر الأخبار والتحديثات وتحليل الاتجاهات
  • استغل قوة تحليل المعايير لتتبع المنافسين بشكل شامل
Request for Demo

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE ASIA PACIFIC MEDICAL CANNABIS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

5 INDUSTRY INSIGHTS

5.1 INDUSTRY INSIGHTS PATENT ANALYSIS

5.2 DRUG TREATMENT RATE BY MATURED MARKETS

5.3 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES

5.4 PATIENT FLOW DIAGRAM

5.5 KEY PRICING STRATEGIES

5.6 KEY PATIENT ENROLLMENT STRATEGIES

 

6 REGULATORY SCENARIO

6.1 AUSTRALIA

6.2 THAILAND

6.3 JAPAN

6.4 CHINA

6.5 NEW ZEALAND

6.6 SINGAPORE

6.7 INDIA

6.8 MALAYSIA

6.9 PHILIPPINES

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASED USE OF CANNABIS IN MEDICINES

7.1.2 LEGALIZATION OF CANNABIS

7.1.3 STRATEGIC INITIATIVES TAKEN BY KEY PLAYERS

7.1.4 RISE IN THE PREVALENCE OF DISEASES THAT REQUIRE THE USE OF CANNABIS

7.2 RESTRAINTS

7.2.1 COMPLEX REGULATORY STRUCTURE FOR THE USAGE OF CANNABIS

7.2.2 ADVERSE EFFECTS DUE TO LONG-TERM USE

7.2.3 HIGH-COST PURCHASING AND RUSH FOR PREMIUM QUALITY

7.3 OPPORTUNITIES

7.3.1 NOVEL PRODUCT DEVELOPMENT WITH INCREASING R&D ACTIVITIES

7.3.2 INCREASED ADOPTION OF CANNABIS FOR RECREATIONAL PURPOSES

7.3.3 GROWING GERIATRIC POPULATION

7.4 CHALLENGES

7.4.1 RISE OF THE CANNABIS BLACK MARKET

7.4.2 SIDE EFFECTS RELATED TO THE USE OF CANNABIS

7.4.3 SHORTAGE OF SKILLED PERSONNEL

8 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY PRODUCT

8.1 OVERVIEW

8.2 OIL

8.2.1 OIL, BY TYPE

8.2.1.1 CBD OIL CONCENTRATES

8.2.1.2 CBD VAPE OIL

8.2.1.3 CBD TINCTURES

8.2.2 OIL, BY SOURCE

8.2.2.1 HEMP BASED

8.2.2.2 MARIJUANA BASED

8.2.3 OIL, BY SPECIES

8.2.3.1 SATIVA

8.2.3.2 HYBRID

8.2.3.3 CANNABIS INDICA

8.2.4 OIL, BY PRODUCT TYPE

8.2.4.1 BRANDED

8.2.4.1.1 PENGUIN CBD OIL

8.2.4.1.2 FAB CBD OIL

8.2.4.1.3 GREEN ROADS BROAD SPECTRUM CBD OIL

8.2.4.1.4 OTHERS

8.2.4.2 GENERIC

8.3 DRIED MEDICAL CANNABIS

8.3.1 CANNABIS INDICA

8.3.2 SATIVA

8.3.3 HYBRID

8.4 MEDICAL CANNABIS CAPSULES

8.4.1 MEDICAL CANNABIS CAPSULES, BY TYPE

8.4.1.1 OIL BASED CANNABIS CAPSULES

8.4.1.2 POWDER BASED CANNABIS CAPSULES

8.4.1.3 LIQUID BASED CANNABIS CAPSULES

8.4.1.4 OTHERS

8.4.2 MEDICAL CANNABIS CAPSULES, BY CONCENTRATES

8.4.2.1 HIGH CBD CAPSULES DIGITAL

8.4.2.2 HIGH THC CAPSULE

8.4.2.3 THC/CBD BALANCED CAPSULE

8.4.2.4 CBD ISOLATE CAPSULE

8.4.3 MEDICAL CANNABIS CAPSULES, BY SPECIES

8.4.3.1 SATIVA

8.4.3.2 CANNABIS INDICA

8.4.4 MEDICAL CANNABIS CAPSULES, BY PRODUCT TYPE

8.4.4.1 BRANDED

8.4.4.1.1 JOY NUTRITION

8.4.4.1.2 MEDTERRA ISOLATE CBD GEL CAPSULES

8.4.4.1.3 LAZARUS NATURALS

8.4.4.1.4 OTHERS

8.4.4.2 GENERIC

 

8.5 VAPE PEN

8.5.1 VAPE PEN, BY SPECIES

8.5.1.1 SATIVA

8.5.1.2 HYBRID

8.5.1.3 CANNABIS INDICA

8.5.2 VAPE PEN, BY PRODUCT TYPE

8.5.2.1 BRANDED

8.5.2.1.1 KANDYPENS RUBI

8.5.2.1.2 SOL E-NECTAR COLLECTOR

8.5.2.1.3 PAX ERA PRO-OIL VAPE PEN

8.5.2.2 GENERIC

8.6 WHOLE FLOWER

8.6.1 WHOLE FLOWER, SPECIES

8.6.1.1 SATIVA

8.6.1.2 HYBRID

8.6.1.3 CANNABIS INDICA

8.6.2 WHOLE FLOWER, PRODUCT TYPE

8.6.2.1 BRANDED

8.6.2.1.1 ASTER FARMS

8.6.2.1.2 RA FLOWER

8.6.2.1.3 BAD APPLE

8.6.2.2 GENERIC

8.7 CREAMS & MOISTURIZER

8.7.1 CREAMS & MOISTURIZER, BY SPECIES

8.7.1.1 SATIVA

8.7.1.2 HYBRID

8.7.1.3 CANNABIS INDICA

8.7.2 CREAMS & MOISTURIZER, BY PRODUCT TYPE

8.7.2.1 BRANDED

8.7.2.1.1 CBDFX MUSCLE & JOINT

8.7.2.1.2 ASPEN GREEN MUSCLE RELIEF COOLING CREAM

8.7.2.1.3 MEDTERRA PAIN CREAM

8.7.2.2 GENERIC

 

8.8 GROUND FLOWER

8.8.1 GROUND FLOWER, BY SPECIES

8.8.1.1 SATIVA

8.8.1.2 HYBRID

8.8.1.3 CANNABIS INDICA

8.8.2 GROUND FLOWER, BY PRODUCT TYPE

8.8.2.1 BRANDED

8.8.2.1.1 ASTER FARMS

8.8.2.1.2 RA FLOWER

8.8.2.1.3 BAD APPLE

8.8.2.2 GENERIC

8.9 PATCH

8.9.1 PATCH, BY TYPE

8.9.1.1 RESERVOIR

8.9.1.2 LAYER DRUG-IN-ADHESIVE

8.9.1.3 OTHERS

8.9.2 PATCH, BY SPECIES

8.9.2.1 SATIVA

8.9.2.2 CANNABIS INDICA

8.9.2.3 HYBRID

8.9.3 PATCH, BY PRODUCT TYPE

8.9.3.1 BRANDED

8.9.3.1.1 HEMP BOMBS

8.9.3.1.2 PUREKANA

8.9.3.1.3 PURE RATIOS

8.9.3.1.4 RESERVOIR

8.9.3.2 GENERIC

8.1 MASKS & SERUM

8.10.1 MASKS & SERUM, BY SPECIES

8.10.1.1 SATIVA

8.10.1.2 CANNABIS INDICA

8.10.1.3 HYBRID

8.10.2 MASKS & SERUM, BY PRODUCT TYPE

8.10.2.1 BRANDED

8.10.2.1.1 BUMP & SMOOTH CBD

8.10.2.1.2 FACIAL ESSENCE

8.10.2.1.3 OTHERS

8.10.2.2 GENERIC

 

8.11 CLEANSER

8.11.1 CLEANSER, BY SPECIES

8.11.1.1 SATIVA

8.11.1.2 HYBRID

8.11.1.3 CANNABIS INDICA

8.11.2 CLEANSER, BY PRODUCT TYPE

8.11.2.1 BRANDED

8.11.2.1.1 KIEHL’S

8.11.2.1.2 CBD 101

8.11.2.1.3 OTHERS

8.11.2.2 GENERIC

8.12 OTHERS

9 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY SPECIES

9.1 OVERVIEW

9.2 SATIVA

9.3 HYBRID

9.4 CANNABIS INDICA

10 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY DERIVATIVES

10.1 OVERVIEW

10.2 CANNABIDIOL (CBD)

10.3 TETRAHYDROCANNABINOL (THC)/DELTA-8-TETRAHYDROCANNABINOL

10.4 CANNABIGEROL (CBG)

10.5 CANNABICHROMENE (CBC)

10.6 CANNABINOL (CBN)

10.7 CANNABICYCLOL (CBL)

10.8 OTHERS

11 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY APPLICATION

11.1 OVERVIEW

11.2 PAIN MANAGEMENT

11.2.1 PAIN MANAGEMENT, BY TYPE

11.2.1.1 CHRONIC PAIN

11.2.1.2 NON-CANCER CHRONIC PAIN

11.2.1.3 NEUROLOGICAL PAIN

 

11.2.2 PAIN MANAGEMENT, BY PRODUCT

11.2.2.1 OIL

11.2.2.2 DRIED MEDICAL CANNABIS

11.2.2.3 MEDICAL CANNABIS CAPSULES

11.2.2.4 PATCH

11.2.2.5 GROUND FLOWER

11.2.2.6 CREAMS & MOISTURIZER

11.2.2.7 VAPE PEN

11.2.2.8 WHOLE FLOWER

11.2.2.9 MASKS & SERUM

11.2.2.10 CLEANSER

11.2.2.11 OTHERS

11.3 ANXIETY

11.3.1 OIL

11.3.2 DRIED MEDICAL CANNABIS

11.3.3 MEDICAL CANNABIS CAPSULES

11.3.4 PATCH

11.3.5 GROUND FLOWER

11.3.6 CREAMS & MOISTURIZER

11.3.7 VAPE PEN

11.3.8 WHOLE FLOWER

11.3.9 MASKS & SERUM

11.3.10 CLEANSER

11.3.11 OTHERS

11.4 MUSCLE SPASM

11.4.1 OIL

11.4.2 DRIED MEDICAL CANNABIS

11.4.3 MEDICAL CANNABIS CAPSULES

11.4.4 PATCH

11.4.5 GROUND FLOWER

11.4.6 CREAMS & MOISTURIZER

11.4.7 VAPE PEN

11.4.8 WHOLE FLOWER

11.4.9 MASKS & SERUM

11.4.10 CLEANSER

11.4.11 OTHERS

 

11.5 NAUSEA

11.5.1 OIL

11.5.2 DRIED MEDICAL CANNABIS

11.5.3 MEDICAL CANNABIS CAPSULES

11.5.4 PATCH

11.5.5 GROUND FLOWER

11.5.6 CREAMS & MOISTURIZER

11.5.7 VAPE PEN

11.5.8 WHOLE FLOWER

11.5.9 MASKS & SERUM

11.5.10 CLEANSER

11.5.11 OTHERS

11.6 APPETITE LOSS

11.6.1 OIL

11.6.2 DRIED MEDICAL CANNABIS

11.6.3 MEDICAL CANNABIS CAPSULES

11.6.4 PATCH

11.6.5 GROUND FLOWER

11.6.6 CREAMS & MOISTURIZER

11.6.7 VAPE PEN

11.6.8 WHOLE FLOWER

11.6.9 MASKS & SERUM

11.6.10 CLEANSER

11.6.11 OTHERS

11.7 EATING DISORDERS

11.7.1 OIL

11.7.2 DRIED MEDICAL CANNABIS

11.7.3 MEDICAL CANNABIS CAPSULES

11.7.4 PATCH

11.7.5 GROUND FLOWER

11.7.6 CREAMS & MOISTURIZER

11.7.7 VAPE PEN

11.7.8 WHOLE FLOWER

11.7.9 MASKS & SERUM

11.7.10 CLEANSER

11.7.11 OTHERS

 

11.8 INFLAMMATORY BOWEL DISEASES

11.8.1 OIL

11.8.2 DRIED MEDICAL CANNABIS

11.8.3 MEDICAL CANNABIS CAPSULES

11.8.4 PATCH

11.8.5 GROUND FLOWER

11.8.6 CREAMS & MOISTURIZER

11.8.7 VAPE PEN

11.8.8 WHOLE FLOWER

11.8.9 MASKS & SERUM

11.8.10 CLEANSER

11.8.11 OTHERS

11.9 CANCER

11.9.1 OIL

11.9.2 DRIED MEDICAL CANNABIS

11.9.3 MEDICAL CANNABIS CAPSULES

11.9.4 PATCH

11.9.5 GROUND FLOWER

11.9.6 CREAMS & MOISTURIZER

11.9.7 VAPE PEN

11.9.8 WHOLE FLOWER

11.9.9 MASKS & SERUM

11.9.10 CLEANSER

11.9.11 OTHERS

11.1 ARTHRITIS

11.10.1 OIL

11.10.2 DRIED MEDICAL CANNABIS

11.10.3 MEDICAL CANNABIS CAPSULES

11.10.4 PATCH

11.10.5 GROUND FLOWER

11.10.6 CREAMS & MOISTURIZER

11.10.7 VAPE PEN

11.10.8 WHOLE FLOWER

11.10.9 MASKS & SERUM

11.10.10 CLEANSER

11.10.11 OTHERS

 

11.11 WASHING SYNDROME (CACHEXIA)

11.11.1 OIL

11.11.2 DRIED MEDICAL CANNABIS

11.11.3 MEDICAL CANNABIS CAPSULES

11.11.4 PATCH

11.11.5 GROUND FLOWER

11.11.6 CREAMS & MOISTURIZER

11.11.7 VAPE PEN

11.11.8 WHOLE FLOWER

11.11.9 MASKS & SERUM

11.11.10 CLEANSER

11.11.11 OTHERS

11.12 ALZHEIMER’S DISEASE

11.12.1 OIL

11.12.2 DRIED MEDICAL CANNABIS

11.12.3 MEDICAL CANNABIS CAPSULES

11.12.4 PATCH

11.12.5 GROUND FLOWER

11.12.6 CREAMS & MOISTURIZER

11.12.7 VAPE PEN

11.12.8 WHOLE FLOWER

11.12.9 MASKS & SERUM

11.12.10 CLEANSER

11.12.11 OTHERS

11.13 EPILEPSY

11.13.1 OIL

11.13.2 DRIED MEDICAL CANNABIS

11.13.3 MEDICAL CANNABIS CAPSULES

11.13.4 PATCH

11.13.5 GROUND FLOWER

11.13.6 CREAMS & MOISTURIZER

11.13.7 VAPE PEN

11.13.8 WHOLE FLOWER

11.13.9 MASKS & SERUM

11.13.10 CLEANSER

11.13.11 OTHERS

 

11.14 DEPRESSION AND SLEEP DISORDER

11.14.1 OIL

11.14.2 DRIED MEDICAL CANNABIS

11.14.3 MEDICAL CANNABIS CAPSULES

11.14.4 PATCH

11.14.5 GROUND FLOWER

11.14.6 CREAMS & MOISTURIZER

11.14.7 VAPE PEN

11.14.8 WHOLE FLOWER

11.14.9 MASKS & SERUM

11.14.10 CLEANSER

11.14.11 OTHERS

11.15 MULTIPLE SCLEROSIS

11.15.1 OIL

11.15.2 DRIED MEDICAL CANNABIS

11.15.3 MEDICAL CANNABIS CAPSULES

11.15.4 PATCH

11.15.5 GROUND FLOWER

11.15.6 CREAMS & MOISTURIZER

11.15.7 VAPE PEN

11.15.8 WHOLE FLOWER

11.15.9 MASKS & SERUM

11.15.10 CLEANSER

11.15.11 OTHERS

11.16 AUTISM

11.16.1 OIL

11.16.2 DRIED MEDICAL CANNABIS

11.16.3 MEDICAL CANNABIS CAPSULES

11.16.4 PATCH

11.16.5 GROUND FLOWER

11.16.6 CREAMS & MOISTURIZER

11.16.7 VAPE PEN

11.16.8 WHOLE FLOWER

11.16.9 MASKS & SERUM

11.16.10 CLEANSER

11.16.11 OTHERS

 

11.17 MENTAL HEALTH CONDITIONS

11.17.1 MENTAL HEALTH CONDITIONS, BY TYPE

11.17.1.1 POSTTRAUMATIC STRESS DISORDER (PTSD)

11.17.1.2 SCHIZOPHRENIA

11.17.1.3 OTHERS

11.17.2 MENTAL HEALTH CONDITIONS, BY TYPE

11.17.2.1 OIL

11.17.2.2 DRIED MEDICAL CANNABIS

11.17.2.3 MEDICAL CANNABIS CAPSULES

11.17.2.4 PATCH

11.17.2.5 GROUND FLOWER

11.17.2.6 CREAMS & MOISTURIZER

11.17.2.7 VAPE PEN

11.17.2.8 WHOLE FLOWER

11.17.2.9 MASKS & SERUM

11.17.2.10 CLEANSER

11.17.2.11 OTHERS

11.18 ELEVATE MOOD

11.18.1 OIL

11.18.2 DRIED MEDICAL CANNABIS

11.18.3 MEDICAL CANNABIS CAPSULES

11.18.4 PATCH

11.18.5 GROUND FLOWER

11.18.6 CREAMS & MOISTURIZER

11.18.7 VAPE PEN

11.18.8 WHOLE FLOWER

11.18.9 MASKS & SERUM

11.18.10 CLEANSER

11.18.11 OTHERS

11.19 OTHERS

12 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION

12.1 OVERVIEW

12.2 ORAL SOLUTIONS AND CAPSULES

12.3 SMOKING

12.4 TOPICALS

12.5 VAPORIZERS

12.6 OTHERS

 

13 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY TREATMENT TYPE

13.1 OVERVIEW

13.2 ANALGESIC

13.3 PSYCHEDELIC

13.4 ANTIVIRAL

13.5 APHRODISIAC

13.6 EXPECTORANT

13.7 OTHERS

14 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY END USER

14.1 OVERVIEW

14.2 HOMECARE SETTING

14.3 HOSPITAL

14.4 REHAB CENTERS

14.5 PHARMACEUTICAL INDUSTRY

14.6 RESEARCH AND DEVELOPMENT CENTERS

14.7 OTHERS

15 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL

15.1 OVERVIEW

15.2 B2C

15.2.1 PHARMACIES

15.2.2 CONVENTIONAL STORES

15.2.3 ONLINE STORES

15.2.4 OTHERS

15.3 B2B

16 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY REGION

16.1 ASIA-PACIFIC

16.1.1 AUSTRALIA

16.1.2 THAILAND

16.1.3 SOUTH KOREA

16.1.4 JAPAN

16.1.5 CHINA

16.1.6 NEW ZEALAND

16.1.7 SINGAPORE

16.1.8 INDIA

16.1.9 TAIWAN

16.1.10 MALAYSIA

16.1.11 PHILIPPINES

16.1.12 REST OF ASIA-PACIFIC

17 ASIA PACIFIC MEDICAL CANNABIS MARKET: COMPANY LANDSCAPE

17.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC

18 COMPANY PROFILE

18.1 MEDIPHARM LABS INC.

18.1.1 COMPANY SNAPSHOT

18.1.2 REVENUE ANALYSIS

18.1.3 COMPANY SHARE ANALYSIS

18.1.4 PRODUCT PORTFOLIO

18.1.5 RECENT DEVELOPMENTS

18.2 TILRAY

18.2.1 COMPANY SNAPSHOT

18.2.2 COMPANY SHARE ANALYSIS

18.2.3 PRODUCT PORTFOLIO

18.2.4 RECENT DEVELOPMENTS

18.3 AURORA CANNABIS

18.3.1 COMPANY SNAPSHOT

18.3.2 REVENUE ANALYSIS

18.3.3 COMPANY SHARE ANALYSIS

18.3.4 PRODUCT PORTFOLIO

18.3.5 RECENT DEVELOPMENTS

18.4 JAZZ PHARMACEUTICALS INC. (GW PHARMACEUTICALS PLC)

18.4.1 COMPANY SNAPSHOT

18.4.2 REVENUE ANALYSIS

18.4.3 COMPANY SHARE ANALYSIS

18.4.4 PRODUCT PORTFOLIO

18.4.5 RECENT DEVELOPMENTS

18.5 HEXO CORP. (ZENABIS ASIA PACIFIC LTD)

18.5.1 COMPANY SNAPSHOT

18.5.2 REVENUE ANALYSIS

18.5.3 COMPANY SHARE ANALYSIS

18.5.4 PRODUCT PORTFOLIO

18.5.5 RECENT DEVELOPMENTS

18.6 APOTHECANNA

18.6.1 COMPANY SNAPSHOT

18.6.2 PRODUCT PORTFOLIO

18.6.3 RECENT DEVELOPMENT

 

18.7 BOL PHARMA

18.7.1 COMPANY SNAPSHOT

18.7.2 PRODUCT PORTFOLIO

18.7.3 RECENT DEVELOPMENTS

18.8 BARNEY’S FARM

18.8.1 COMPANY SNAPSHOT

18.8.2 PRODUCT PORTFOLIO

18.8.3 RECENT DEVELOPMENTS

18.9 CANOPY GROWTH CORPORATION

18.9.1 COMPANY SNAPSHOT

18.9.2 REVENUE ANALYSIS

18.9.3 PRODUCT PORTFOLIO

18.9.4 RECENT DEVELOPMENTS

18.1 CANNABIS SEEDS USA

18.10.1 COMPANY SNAPSHOT

18.10.2 PRODUCT PORTFOLIO

18.10.3 RECENT DEVELOPMENT

18.11 CRESCO LABS

18.11.1 COMPANY SNAPSHOT

18.11.2 PRODUCT PORTFOLIO

18.11.3 RECENT DEVELOPMENTS

18.12 ECOGEN BIOSCIENCES

18.12.1 COMPANY SNAPSHOT

18.12.2 PRODUCT PORTFOLIO

18.12.3 RECENT DEVELOPMENTS

18.13 ELIXINOL ASIA PACIFIC LIMITED

18.13.1 COMPANY SNAPSHOT

18.13.2 REVENUE ANALYSIS

18.13.3 PRODUCT PORTFOLIO

18.13.4 RECENT DEVELOPMENTS

18.14 ENDOCA

18.14.1 COMPANY SNAPSHOT

18.14.2 PRODUCT PORTFOLIO

18.14.3 RECENT DEVELOPMENT

18.15 EXTRACTAS

18.15.1 COMPANY SNAPSHOT

18.15.2 PRODUCT PORTFOLIO

18.15.3 RECENT DEVELOPMENT

 

18.16 FOLIUM BIOSCIENCES

18.16.1 COMPANY SNAPSHOT

18.16.2 PRODUCT PORTFOLIO

18.16.3 RECENT DEVELOPMENTS

18.17 GREENWICH BIOSCIENCES, INC.

18.17.1 COMPANY SNAPSHOT

18.17.2 PRODUCT PORTFOLIO

18.17.3 RECENT DEVELOPMENTS

18.18 HARMONY

18.18.1 COMPANY SNAPSHOT

18.18.2 PRODUCT PORTFOLIO

18.18.3 RECENT DEVELOPMENTS

18.19 HUMBOLDT SEED COMPANY

18.19.1 COMPANY SNAPSHOT

18.19.2 PRODUCT PORTFOLIO

18.19.3 RECENT DEVELOPMENT

18.2 IDT AUSTRALIA

18.20.1 COMPANY SNAPSHOT

18.20.2 REVENUE ANALYSIS

18.20.3 PRODUCT PORTFOLIO

18.20.4 RECENT DEVELOPMENTS

18.21 MARY’S NUTRITIONALS, LLC

18.21.1 COMPANY SNAPSHOT

18.21.2 PRODUCT PORTFOLIO

18.21.3 RECENT DEVELOPMENT

18.22 MEDICAL MARIJUANA, INC.

18.22.1 COMPANY SNAPSHOT

18.22.2 REVENUE ANALYSIS

18.22.3 PRODUCT PORTFOLIO

18.22.4 RECENT DEVELOPMENTS

18.23 PEACE NATURALS PROJECT INC.

18.23.1 COMPANY SNAPSHOT

18.23.2 PRODUCT PORTFOLIO

18.23.3 RECENT DEVELOPMENT

18.24 PHARMAHEMP

18.24.1 COMPANY SNAPSHOT

18.24.2 PRODUCT PORTFOLIO

18.24.3 RECENT DEVELOPMENT

 

18.25 PURE RATIOS

18.25.1 COMPANY SNAPSHOT

18.25.2 PRODUCT PORTFOLIO

18.25.3 RECENT DEVELOPMENT

18.26 SEEDS FOR ME

18.26.1 COMPANY SNAPSHOT

18.26.2 PRODUCT PORTFOLIO

18.26.3 RECENT DEVELOPMENT

18.27 SEED CELLAR

18.27.1 COMPANY SNAPSHOT

18.27.2 PRODUCT PORTFOLIO

18.27.3 RECENT DEVELOPMENT

18.28 UPSTATE ELEVATOR SUPPLY CO.

18.28.1 COMPANY SNAPSHOT

18.28.2 PRODUCT PORTFOLIO

18.28.3 RECENT DEVELOPMENT

18.29 WORLD CLASS CANNABIS SEEDS (CROP KING SEEDS)

18.29.1 COMPANY SNAPSHOT

18.29.2 PRODUCT PORTFOLIO

18.29.3 RECENT DEVELOPMENT

19 QUESTIONNAIRE

20 RELATED REPORTS

List of Table

TABLE 1 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 2 ASIA PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 3 ASIA PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 4 ASIA PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 5 ASIA PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 6 ASIA PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)

TABLE 7 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 8 ASIA PACIFIC DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 9 ASIA PACIFIC DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 10 ASIA PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 11 ASIA PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 12 ASIA PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 13 ASIA PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 14 ASIA PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 15 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 16 ASIA PACIFIC VAPE PEN IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 17 ASIA PACIFIC VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 18 ASIA PACIFIC VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 19 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 20 ASIA PACIFIC WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 21 ASIA PACIFIC WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 22 ASIA PACIFIC WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 23 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 24 ASIA PACIFIC CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 25 ASIA PACIFIC CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 26 ASIA PACIFIC CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 27 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 28 ASIA PACIFIC GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 29 ASIA PACIFIC GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 30 ASIA PACIFIC GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 31 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 32 ASIA PACIFIC PATCH IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 33 ASIA PACIFIC PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 34 ASIA PACIFIC PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 35 ASIA PACIFIC PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 36 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 37 ASIA PACIFIC MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 38 ASIA PACIFIC MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 39 ASIA PACIFIC MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 40 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 41 ASIA PACIFIC CLEANSER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 42 ASIA PACIFIC CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 43 ASIA PACIFIC CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 44 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 45 ASIA PACIFIC OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 46 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 47 ASIA PACIFIC SATIVA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 48 ASIA PACIFIC HYBRID IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 49 ASIA PACIFIC CANNABIS INDICA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 50 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 51 ASIA PACIFIC CANNABIDIOL (CBD) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 52 ASIA PACIFIC TETRAHYDROCANNABINOL (THC)/DELTA-8-TETRAHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 53 ASIA PACIFIC CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 54 ASIA PACIFIC CANNABICHROMENE (CBC) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 55 ASIA PACIFIC CANNABINOL (CBN) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 56 ASIA PACIFIC CANNABICYCLOL (CBL) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 57 ASIA PACIFIC OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 58 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 59 ASIA PACIFIC PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 60 ASIA PACIFIC PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 61 ASIA PACIFIC PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 62 ASIA PACIFIC ANXIETY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 63 ASIA PACIFIC ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 64 ASIA PACIFIC MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 65 ASIA PACIFIC MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 66 ASIA PACIFIC NAUSEA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 67 ASIA PACIFIC NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 68 ASIA PACIFIC APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 69 ASIA PACIFIC APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 70 ASIA PACIFIC EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 71 ASIA PACIFIC EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 72 ASIA PACIFIC INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 73 ASIA PACIFIC INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 74 ASIA PACIFIC CANCER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 75 ASIA PACIFIC CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 76 ASIA PACIFIC ARTHRITIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 77 ASIA PACIFIC ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 78 ASIA PACIFIC WASHING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 79 ASIA PACIFIC WASHING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 80 ASIA PACIFIC ALZHEIMER’S DISEASE IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 81 ASIA PACIFIC ALZHEIMER’S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 82 ASIA PACIFIC EPILEPSY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 83 ASIA PACIFIC EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 84 ASIA PACIFIC DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 85 ASIA PACIFIC DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 86 ASIA PACIFIC MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 87 ASIA PACIFIC MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 88 ASIA PACIFIC AUTISM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 89 ASIA PACIFIC AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 90 ASIA PACIFIC MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 91 ASIA PACIFIC MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 92 ASIA PACIFIC MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 93 ASIA PACIFIC ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 94 ASIA PACIFIC ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 95 ASIA PACIFIC OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 96 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 97 ASIA PACIFIC ORAL SOLUTIONS AND CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 98 ASIA PACIFIC SMOKING IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 99 ASIA PACIFIC TOPICALS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 100 ASIA PACIFIC VAPORIZERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 101 ASIA PACIFIC OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 102 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 103 ASIA PACIFIC ANALGESIC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 104 ASIA PACIFIC PSYCHEDELIC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 105 ASIA PACIFIC ANTIVIRAL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 106 ASIA PACIFIC APHRODISIAC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 107 ASIA PACIFIC EXPECTORANT IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 108 ASIA PACIFIC OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 109 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 110 ASIA PACIFIC HOMECARE SETTING IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 111 ASIA PACIFIC HOSPITAL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 112 ASIA PACIFIC REHAB CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 113 ASIA PACIFIC PHARMACEUTICAL INDUSTRY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 114 ASIA PACIFIC RESEARCH AND DEVELOPMENT CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 115 ASIA PACIFIC OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 116 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 117 ASIA PACIFIC B2C IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 118 ASIA PACIFIC B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 119 ASIA PACIFIC B2B IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 120 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 121 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 122 ASIA-PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 123 ASIA-PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 124 ASIA-PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 125 ASIA-PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 126 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 127 ASIA-PACIFIC DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 128 ASIA-PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 129 ASIA-PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 130 ASIA-PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 131 ASIA-PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 132 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 133 ASIA-PACIFIC VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 134 ASIA-PACIFIC VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 135 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 136 ASIA-PACIFIC WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 137 ASIA-PACIFIC WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 138 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 139 ASIA-PACIFIC CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 140 ASIA-PACIFIC CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 141 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 142 ASIA-PACIFIC GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 143 ASIA-PACIFIC GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 144 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 145 ASIA-PACIFIC PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 146 ASIA-PACIFIC PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 147 ASIA-PACIFIC PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 148 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 149 ASIA-PACIFIC MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 150 ASIA-PACIFIC MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 151 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 152 ASIA-PACIFIC CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 153 ASIA-PACIFIC CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 154 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 155 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 156 ASIA-PACIFIC SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 157 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 158 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 159 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 160 ASIA-PACIFIC PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 161 ASIA-PACIFIC PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 162 ASIA-PACIFIC ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 163 ASIA-PACIFIC MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 164 ASIA-PACIFIC NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 165 ASIA-PACIFIC APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 166 ASIA-PACIFIC EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 167 ASIA-PACIFIC INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 168 ASIA-PACIFIC CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 169 ASIA-PACIFIC ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 170 ASIA-PACIFIC WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 171 ASIA-PACIFIC ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 172 ASIA-PACIFIC EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 173 ASIA-PACIFIC DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 174 ASIA-PACIFIC MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 175 ASIA-PACIFIC AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 176 ASIA-PACIFIC MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 177 ASIA-PACIFIC MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 178 ASIA-PACIFIC ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 179 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 180 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 181 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 182 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 183 ASIA-PACIFIC B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 184 AUSTRALIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 185 AUSTRALIA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 186 AUSTRALIA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 187 AUSTRALIA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 188 AUSTRALIA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 189 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 190 AUSTRALIA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 191 AUSTRALIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 192 AUSTRALIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 193 AUSTRALIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 194 AUSTRALIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 195 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 196 AUSTRALIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 197 AUSTRALIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 198 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 199 AUSTRALIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 200 AUSTRALIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 201 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 202 AUSTRALIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 203 AUSTRALIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 204 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 205 AUSTRALIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 206 AUSTRALIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 207 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 208 AUSTRALIA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 209 AUSTRALIA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 210 AUSTRALIA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 211 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 212 AUSTRALIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 213 AUSTRALIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 214 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 215 AUSTRALIA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 216 AUSTRALIA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 217 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 218 AUSTRALIA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 219 AUSTRALIA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 220 AUSTRALIA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 221 AUSTRALIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 222 AUSTRALIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 223 AUSTRALIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 224 AUSTRALIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 225 AUSTRALIA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 226 AUSTRALIA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 227 AUSTRALIA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 228 AUSTRALIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 229 AUSTRALIA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 230 AUSTRALIA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 231 AUSTRALIA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 232 AUSTRALIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 233 AUSTRALIA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 234 AUSTRALIA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 235 AUSTRALIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 236 AUSTRALIA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 237 AUSTRALIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 238 AUSTRALIA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 239 AUSTRALIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 240 AUSTRALIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 241 AUSTRALIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 242 AUSTRALIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 243 AUSTRALIA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 244 AUSTRALIA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 245 AUSTRALIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 246 AUSTRALIA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 247 THAILAND MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 248 THAILAND OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 249 THAILAND OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 250 THAILAND OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 251 THAILAND OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 252 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 253 THAILAND DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 254 THAILAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 255 THAILAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 256 THAILAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 257 THAILAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 258 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 259 THAILAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 260 THAILAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 261 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 262 THAILAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 263 THAILAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 264 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 265 THAILAND CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 266 THAILAND CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 267 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 268 THAILAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 269 THAILAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 270 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 271 THAILAND PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 272 THAILAND PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 273 THAILAND PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 274 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 275 THAILAND MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 276 THAILAND MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 277 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 278 THAILAND CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 279 THAILAND CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 280 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 281 THAILAND MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 282 THAILAND SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 283 THAILAND MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 284 THAILAND MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 285 THAILAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 286 THAILAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 287 THAILAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 288 THAILAND ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 289 THAILAND MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 290 THAILAND NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 291 THAILAND APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 292 THAILAND EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 293 THAILAND INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 294 THAILAND CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 295 THAILAND ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 296 THAILAND WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 297 THAILAND ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 298 THAILAND EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 299 THAILAND DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 300 THAILAND MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 301 THAILAND AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 302 THAILAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 303 THAILAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 304 THAILAND ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 305 THAILAND MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 306 THAILAND MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 307 THAILAND MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 308 THAILAND MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 309 THAILAND B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 310 SOUTH KOREA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 311 SOUTH KOREA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 312 SOUTH KOREA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 313 SOUTH KOREA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 314 SOUTH KOREA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 315 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 316 SOUTH KOREA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 317 SOUTH KOREA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 318 SOUTH KOREA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 319 SOUTH KOREA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 320 SOUTH KOREA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 321 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 322 SOUTH KOREA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 323 SOUTH KOREA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 324 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 325 SOUTH KOREA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 326 SOUTH KOREA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 327 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 328 SOUTH KOREA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 329 SOUTH KOREA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 330 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 331 SOUTH KOREA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 332 SOUTH KOREA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 333 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 334 SOUTH KOREA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 335 SOUTH KOREA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 336 SOUTH KOREA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 337 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 338 SOUTH KOREA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 339 SOUTH KOREA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 340 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 341 SOUTH KOREA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 342 SOUTH KOREA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 343 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 344 SOUTH KOREA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 345 SOUTH KOREA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 346 SOUTH KOREA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 347 SOUTH KOREA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 348 SOUTH KOREA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 349 SOUTH KOREA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 350 SOUTH KOREA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 351 SOUTH KOREA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 352 SOUTH KOREA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 353 SOUTH KOREA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 354 SOUTH KOREA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 355 SOUTH KOREA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 356 SOUTH KOREA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 357 SOUTH KOREA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 358 SOUTH KOREA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 359 SOUTH KOREA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 360 SOUTH KOREA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 361 SOUTH KOREA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 362 SOUTH KOREA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 363 SOUTH KOREA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 364 SOUTH KOREA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 365 SOUTH KOREA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 366 SOUTH KOREA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 367 SOUTH KOREA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 368 SOUTH KOREA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 369 SOUTH KOREA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 370 SOUTH KOREA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 371 SOUTH KOREA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 372 SOUTH KOREA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 373 JAPAN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 374 JAPAN OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 375 JAPAN OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 376 JAPAN OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 377 JAPAN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 378 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 379 JAPAN DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 380 JAPAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 381 JAPAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 382 JAPAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 383 JAPAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 384 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 385 JAPAN VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 386 JAPAN VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 387 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 388 JAPAN WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 389 JAPAN WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 390 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 391 JAPAN CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 392 JAPAN CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 393 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 394 JAPAN GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 395 JAPAN GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 396 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 397 JAPAN PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 398 JAPAN PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 399 JAPAN PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 400 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 401 JAPAN MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 402 JAPAN MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 403 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 404 JAPAN CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 405 JAPAN CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 406 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 407 JAPAN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 408 JAPAN SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 409 JAPAN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 410 JAPAN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 411 JAPAN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 412 JAPAN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 413 JAPAN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 414 JAPAN ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 415 JAPAN MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 416 JAPAN NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 417 JAPAN APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 418 JAPAN EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 419 JAPAN INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 420 JAPAN CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 421 JAPAN ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 422 JAPAN WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 423 JAPAN ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 424 JAPAN EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 425 JAPAN DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 426 JAPAN MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 427 JAPAN AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 428 JAPAN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 429 JAPAN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 430 JAPAN ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 431 JAPAN MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 432 JAPAN MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 433 JAPAN MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 434 JAPAN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 435 JAPAN B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 436 CHINA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 437 CHINA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 438 CHINA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 439 CHINA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 440 CHINA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 441 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 442 CHINA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 443 CHINA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 444 CHINA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 445 CHINA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 446 CHINA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 447 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 448 CHINA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 449 CHINA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 450 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 451 CHINA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 452 CHINA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 453 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 454 CHINA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 455 CHINA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 456 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 457 CHINA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 458 CHINA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 459 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 460 CHINA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 461 CHINA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 462 CHINA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 463 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 464 CHINA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 465 CHINA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 466 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 467 CHINA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 468 CHINA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 469 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 470 CHINA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 471 CHINA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 472 CHINA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 473 CHINA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 474 CHINA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 475 CHINA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 476 CHINA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 477 CHINA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 478 CHINA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 479 CHINA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 480 CHINA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 481 CHINA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 482 CHINA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 483 CHINA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 484 CHINA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 485 CHINA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 486 CHINA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 487 CHINA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 488 CHINA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 489 CHINA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 490 CHINA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 491 CHINA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 492 CHINA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 493 CHINA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 494 CHINA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 495 CHINA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 496 CHINA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 497 CHINA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 498 CHINA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 499 NEW ZEALAND MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 500 NEW ZEALAND OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 501 NEW ZEALAND OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 502 NEW ZEALAND OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 503 NEW ZEALAND OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 504 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 505 NEW ZEALAND DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 506 NEW ZEALAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 507 NEW ZEALAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 508 NEW ZEALAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 509 NEW ZEALAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 510 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 511 NEW ZEALAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 512 NEW ZEALAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 513 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 514 NEW ZEALAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 515 NEW ZEALAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 516 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 517 NEW ZEALAND CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 518 NEW ZEALAND CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 519 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 520 NEW ZEALAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 521 NEW ZEALAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 522 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 523 NEW ZEALAND PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 524 NEW ZEALAND PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 525 NEW ZEALAND PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 526 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 527 NEW ZEALAND MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 528 NEW ZEALAND MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 529 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 530 NEW ZEALAND CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 531 NEW ZEALAND CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 532 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 533 NEW ZEALAND MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 534 NEW ZEALAND SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 535 NEW ZEALAND MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 536 NEW ZEALAND MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 537 NEW ZEALAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 538 NEW ZEALAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 539 NEW ZEALAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 540 NEW ZEALAND ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 541 NEW ZEALAND MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 542 NEW ZEALAND NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 543 NEW ZEALAND APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 544 NEW ZEALAND EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 545 NEW ZEALAND INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 546 NEW ZEALAND CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 547 NEW ZEALAND ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 548 NEW ZEALAND WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 549 NEW ZEALAND ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 550 NEW ZEALAND EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 551 NEW ZEALAND DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 552 NEW ZEALAND MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 553 NEW ZEALAND AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 554 NEW ZEALAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 555 NEW ZEALAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 556 NEW ZEALAND ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 557 NEW ZEALAND MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 558 NEW ZEALAND MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 559 NEW ZEALAND MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 560 NEW ZEALAND MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 561 NEW ZEALAND B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 562 SINGAPORE MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 563 SINGAPORE OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 564 SINGAPORE OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 565 SINGAPORE OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 566 SINGAPORE OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 567 SINGAPORE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 568 SINGAPORE DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 569 SINGAPORE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 570 SINGAPORE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 571 SINGAPORE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 572 SINGAPORE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 573 SINGAPORE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 574 SINGAPORE VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 575 SINGAPORE VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 576 SINGAPORE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 577 SINGAPORE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 578 SINGAPORE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 579 SINGAPORE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 580 SINGAPORE CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 581 SINGAPORE CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 582 SINGAPORE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 583 SINGAPORE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 584 SINGAPORE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 585 SINGAPORE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 586 SINGAPORE PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 587 SINGAPORE PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 588 SINGAPORE PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 589 SINGAPORE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 590 SINGAPORE MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 591 SINGAPORE MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 592 SINGAPORE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 593 SINGAPORE CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 594 SINGAPORE CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 595 SINGAPORE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 596 SINGAPORE MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 597 SINGAPORE SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 598 SINGAPORE MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 599 SINGAPORE MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 600 SINGAPORE MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 601 SINGAPORE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 602 SINGAPORE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 603 SINGAPORE ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 604 SINGAPORE MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 605 SINGAPORE NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 606 SINGAPORE APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 607 SINGAPORE EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 608 SINGAPORE INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 609 SINGAPORE CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 610 SINGAPORE ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 611 SINGAPORE WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 612 SINGAPORE ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 613 SINGAPORE EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 614 SINGAPORE DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 615 SINGAPORE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 616 SINGAPORE AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 617 SINGAPORE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 618 SINGAPORE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 619 SINGAPORE ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 620 SINGAPORE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 621 SINGAPORE MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 622 SINGAPORE MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 623 SINGAPORE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 624 SINGAPORE B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 625 INDIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 626 INDIA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 627 INDIA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 628 INDIA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 629 INDIA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 630 INDIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 631 INDIA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 632 INDIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 633 INDIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 634 INDIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 635 INDIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 636 INDIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 637 INDIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 638 INDIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 639 INDIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 640 INDIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 641 INDIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 642 INDIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 643 INDIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 644 INDIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 645 INDIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 646 INDIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 647 INDIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 648 INDIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 649 INDIA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 650 INDIA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 651 INDIA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 652 INDIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 653 INDIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 654 INDIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 655 INDIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 656 INDIA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 657 INDIA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 658 INDIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 659 INDIA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 660 INDIA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 661 INDIA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 662 INDIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 663 INDIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 664 INDIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 665 INDIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 666 INDIA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 667 INDIA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 668 INDIA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 669 INDIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 670 INDIA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 671 INDIA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 672 INDIA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 673 INDIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 674 INDIA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 675 INDIA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 676 INDIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 677 INDIA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 678 INDIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 679 INDIA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 680 INDIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 681 INDIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 682 INDIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 683 INDIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 684 INDIA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 685 INDIA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 686 INDIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 687 INDIA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 688 TAIWAN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 689 TAIWAN OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 690 TAIWAN OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 691 TAIWAN OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 692 TAIWAN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 693 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 694 TAIWAN DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 695 TAIWAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 696 TAIWAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 697 TAIWAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 698 TAIWAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 699 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 700 TAIWAN VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 701 TAIWAN VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 702 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 703 TAIWAN WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 704 TAIWAN WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 705 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 706 TAIWAN CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 707 TAIWAN CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 708 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 709 TAIWAN GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 710 TAIWAN GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 711 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 712 TAIWAN PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 713 TAIWAN PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 714 TAIWAN PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 715 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 716 TAIWAN MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 717 TAIWAN MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 718 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 719 TAIWAN CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 720 TAIWAN CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 721 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 722 TAIWAN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 723 TAIWAN SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 724 TAIWAN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 725 TAIWAN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 726 TAIWAN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 727 TAIWAN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 728 TAIWAN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 729 TAIWAN ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 730 TAIWAN MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 731 TAIWAN NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 732 TAIWAN APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 733 TAIWAN EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 734 TAIWAN INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 735 TAIWAN CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 736 TAIWAN ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 737 TAIWAN WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 738 TAIWAN ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 739 TAIWAN EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 740 TAIWAN DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 741 TAIWAN MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 742 TAIWAN AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 743 TAIWAN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 744 TAIWAN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 745 TAIWAN ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 746 TAIWAN MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 747 TAIWAN MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 748 TAIWAN MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 749 TAIWAN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 750 TAIWAN B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 751 MALAYSIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 752 MALAYSIA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 753 MALAYSIA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 754 MALAYSIA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 755 MALAYSIA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 756 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 757 MALAYSIA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 758 MALAYSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 759 MALAYSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 760 MALAYSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 761 MALAYSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 762 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 763 MALAYSIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 764 MALAYSIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 765 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 766 MALAYSIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 767 MALAYSIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 768 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 769 MALAYSIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 770 MALAYSIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 771 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 772 MALAYSIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 773 MALAYSIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 774 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 775 MALAYSIA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 776 MALAYSIA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 777 MALAYSIA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 778 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 779 MALAYSIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 780 MALAYSIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 781 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 782 MALAYSIA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 783 MALAYSIA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 784 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 785 MALAYSIA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 786 MALAYSIA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 787 MALAYSIA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 788 MALAYSIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 789 MALAYSIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 790 MALAYSIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 791 MALAYSIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 792 MALAYSIA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 793 MALAYSIA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 794 MALAYSIA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 795 MALAYSIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 796 MALAYSIA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 797 MALAYSIA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 798 MALAYSIA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 799 MALAYSIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 800 MALAYSIA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 801 MALAYSIA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 802 MALAYSIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 803 MALAYSIA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 804 MALAYSIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 805 MALAYSIA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 806 MALAYSIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 807 MALAYSIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 808 MALAYSIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 809 MALAYSIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 810 MALAYSIA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 811 MALAYSIA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 812 MALAYSIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 813 MALAYSIA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 814 PHILIPPINES MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 815 PHILIPPINES OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 816 PHILIPPINES OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 817 PHILIPPINES OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 818 PHILIPPINES OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 819 PHILIPPINES BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 820 PHILIPPINES DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 821 PHILIPPINES MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 822 PHILIPPINES MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 823 PHILIPPINES MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 824 PHILIPPINES MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 825 PHILIPPINES BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 826 PHILIPPINES VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 827 PHILIPPINES VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 828 PHILIPPINES BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 829 PHILIPPINES WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 830 PHILIPPINES WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 831 PHILIPPINES BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 832 PHILIPPINES CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 833 PHILIPPINES CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 834 PHILIPPINES BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 835 PHILIPPINES GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 836 PHILIPPINES GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 837 PHILIPPINES BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 838 PHILIPPINES PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 839 PHILIPPINES PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 840 PHILIPPINES PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 841 PHILIPPINES BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 842 PHILIPPINES MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 843 PHILIPPINES MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 844 PHILIPPINES BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 845 PHILIPPINES CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 846 PHILIPPINES CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 847 PHILIPPINES BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 848 PHILIPPINES MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 849 PHILIPPINES SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 850 PHILIPPINES MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 851 PHILIPPINES MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 852 PHILIPPINES MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 853 PHILIPPINES PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 854 PHILIPPINES PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 855 PHILIPPINES ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 856 PHILIPPINES MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 857 PHILIPPINES NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 858 PHILIPPINES APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 859 PHILIPPINES EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 860 PHILIPPINES INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 861 PHILIPPINES CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 862 PHILIPPINES ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 863 PHILIPPINES WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 864 PHILIPPINES ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 865 PHILIPPINES EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 866 PHILIPPINES DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 867 PHILIPPINES MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 868 PHILIPPINES AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 869 PHILIPPINES MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 870 PHILIPPINES MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 871 PHILIPPINES ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 872 PHILIPPINES MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 873 PHILIPPINES MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 874 PHILIPPINES MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 875 PHILIPPINES MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 876 PHILIPPINES B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 877 REST OF ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

List of Figure

FIGURE 1 ASIA PACIFIC MEDICAL CANNABIS MARKET: SEGMENTATION

FIGURE 2 ASIA PACIFIC MEDICAL CANNABIS MARKET: DATA TRIANGULATION

FIGURE 3 ASIA PACIFIC MEDICAL CANNABIS MARKET: DROC ANALYSIS

FIGURE 4 ASIA PACIFIC MEDICAL CANNABIS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA PACIFIC MEDICAL CANNABIS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA PACIFIC MEDICAL CANNABIS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 ASIA PACIFIC MEDICAL CANNABIS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 ASIA PACIFIC MEDICAL CANNABIS MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 ASIA PACIFIC MEDICAL CANNABIS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 ASIA PACIFIC MEDICAL CANNABIS MARKET: SEGMENTATION

FIGURE 11 INCREASING MEDICINAL USE AND LEGALIZATION OF MEDICAL CANNABIS ARE EXPECTED TO DRIVE THE ASIA PACIFIC MEDICAL CANNABIS MARKET IN THE FORECAST PERIOD OF 2023 TO 2030

FIGURE 12 PRODUCT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC MEDICAL CANNABIS MARKET IN 2023 AND 2030

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC MEDICAL CANNABIS MARKET

FIGURE 14 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY PRODUCT, 2022

FIGURE 15 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY PRODUCT, 2023-2030 (USD MILLION)

FIGURE 16 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY PRODUCT, CAGR (2023-2030)

FIGURE 17 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 18 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY SPECIES, 2022

FIGURE 19 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY SPECIES, 2023-2030 (USD MILLION)

FIGURE 20 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY SPECIES, CAGR (2023-2030)

FIGURE 21 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY SPECIES, LIFELINE CURVE

FIGURE 22 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY DERIVATIVES, 2022

FIGURE 23 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY DERIVATIVES, 2023-2030 (USD MILLION)

FIGURE 24 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY DERIVATIVES, CAGR (2023-2030)

FIGURE 25 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY DERIVATIVES, LIFELINE CURVE

FIGURE 26 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY APPLICATION, 2022

FIGURE 27 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY APPLICATION , 2023-2030 (USD MILLION)

FIGURE 28 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY APPLICATION , CAGR (2023-2030)

FIGURE 29 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 30 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, 2022

FIGURE 31 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)

FIGURE 32 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)

FIGURE 33 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 34 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, 2022

FIGURE 35 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, 2023-2030 (USD MILLION)

FIGURE 36 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, CAGR (2023-2030)

FIGURE 37 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, LIFELINE CURVE

FIGURE 38 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY END USER, 2022

FIGURE 39 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 40 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY END USER, CAGR (2023-2030)

FIGURE 41 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY END USER, LIFELINE CURVE

FIGURE 42 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 43 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 44 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 45 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 46 ASIA-PACIFIC MEDICAL CANNABIS MARKET: SNAPSHOT (2022)

FIGURE 47 ASIA-PACIFIC MEDICAL CANNABIS MARKET: BY COUNTRY (2022)

FIGURE 48 ASIA-PACIFIC MEDICAL CANNABIS MARKET: BY COUNTRY (2023 & 2030)

FIGURE 49 ASIA-PACIFIC MEDICAL CANNABIS MARKET: BY COUNTRY (2022 & 2030)

FIGURE 50 ASIA-PACIFIC MEDICAL CANNABIS MARKET: BY PRODUCT (2023-2030)

FIGURE 51 ASIA PACIFIC MEDICAL CANNABIS MARKET: COMPANY SHARE 2022 (%)

View Detailed Information Right Arrow

منهجية البحث

يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. تتضمن المرحلة الحصول على معلومات السوق أو البيانات ذات الصلة من خلال مصادر واستراتيجيات مختلفة. تتضمن فحص وتخطيط جميع البيانات المكتسبة من الماضي مسبقًا. كما تتضمن فحص التناقضات في المعلومات التي شوهدت عبر مصادر المعلومات المختلفة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. كما أن تحليل حصة السوق وتحليل الاتجاهات الرئيسية هي عوامل النجاح الرئيسية في تقرير السوق. لمعرفة المزيد، يرجى طلب مكالمة محلل أو إرسال استفسارك.

منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي التثليث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأولي (من قبل خبراء الصناعة). تتضمن نماذج البيانات شبكة تحديد موقف البائعين، وتحليل خط زمني للسوق، ونظرة عامة على السوق ودليل، وشبكة تحديد موقف الشركة، وتحليل براءات الاختراع، وتحليل التسعير، وتحليل حصة الشركة في السوق، ومعايير القياس، وتحليل حصة البائعين على المستوى العالمي مقابل الإقليمي. لمعرفة المزيد عن منهجية البحث، أرسل استفسارًا للتحدث إلى خبراء الصناعة لدينا.

التخصيص متاح

تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. ونحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. ويمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان)، وبيانات نتائج التجارب السريرية، ومراجعة الأدبيات، وتحليل السوق المجدد وقاعدة المنتج. ويمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. ويمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. ويمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (كتاب الحقائق) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.

Frequently Asked Questions

The Asia-Pacific Medical Cannabis Market is projected to grow at a CAGR of 22.3% during the forecast period by 2030.
The Asia-Pacific Medical Cannabis Market is segmented on the basis of product, source, species, derivatives, application, route of administration, treatment type, end user, and distribution channel.
The major players in the Asia-Pacific Medical Cannabis Market are MediPharm Labs Inc., Tilray, Aurora Cannabis, JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc), HEXO Corp. (Zenabis Global Ltd), Cresco Labs, Peace Naturals Project Inc., CANOPY GROWTH CORPORATION, etc.
The countries covered in the Asia-Pacific Medical Cannabis Market are Australia, Thailand, South Korea, Japan, China, New Zealand, Singapore, India, Taiwan, Malaysia, Philippines, and Rest of Asia-Pacific.

تصفح الصفحات ذات الصلة

Banner